MORNING LIGHT IP
Please note: Gerben IP does not represent MORNING LIGHT IP, LLC. This page is provided for informational purposes and reflects information available in public USPTO records.
August 31, 2023
Please note: While we make every effort to ensure that the information provided is accurate and up-to-date, we cannot be held responsible for its accuracy or completeness. If you have any questions regarding a specific entity in Gerben's Trademark Library®, please contact us and we will work with you to provide the information you need.
IC 036. US 100 101 102. G & S real estate services, namely, the management and leasing of real estate. FIRST USE: 20210601. FIRST USE IN COMMERCE: 20210601.
IC 040. US 100 103 106. G & S Manufacturing services for others in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; Manufacturing process consulting.
IC 042. US 100 101. G & S Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Research and development of new products for others; Process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; Scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; Quality control for others; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Material testing; Product quality testing; Scientific laboratory services; Scientific research.
IC 045. US 100 101. G & S Regulatory compliance consulting in the fields of pharmaceuticals, medicines, biopharmaceuticals, and gene therapy.
IC 036. US 100 101 102. G & S Real estate services, namely, the management and leasing of real estate. FIRST USE: 20170000. FIRST USE IN COMMERCE: 20180100.
IC 036. US 100 101 102. G & S Real estate services, namely, the management and leasing of real estate. FIRST USE: 20210601. FIRST USE IN COMMERCE: 20210601.
IC 005. US 006 018 044 046 051 052. G & S Pharmaceutical preparations and substances for treatment of upper and lower respiratory diseases and disorders; surfactant replacement therapies for respiratory diseases; pulmonary lung surfactants; inhaled pharmaceutical products for all human respiratory indications; respiratory stimulants. FIRST USE: 20080728. FIRST USE IN COMMERCE: 20080728.
IC 010. US 026 039 044. G & S [ Electric warming units for heating medication ]. FIRST USE: 20050414. FIRST USE IN COMMERCE: 20050630.